BD to Present at Bank of America Securities Health Care Conference
Rhea-AI Summary
BD (NYSE: BDX) will present at the Bank of America Securities Health Care Conference on Tuesday, May 12, 2026 at 11:40 AM ET. The presentation will be webcast live; a replay will be available on BD's investor relations website at investors.bd.com after the event.
Positive
- None.
Negative
- None.
News Market Reaction – BDX
In the Apr 28 session, BDX declined 0.47%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 16 | Industry awards | Positive | -0.5% | Recognition for transparency, resiliency and partnership in supply chain performance. |
| Apr 09 | Earnings date set | Neutral | -0.8% | Announcement of date and webcast details for Q2 FY26 earnings release. |
| Apr 09 | Executive retirement | Neutral | -0.8% | Planned retirement of Interventional segment leader with transition period through June 2026. |
| Apr 09 | Clinical findings | Positive | -1.0% | Trial data showing PureWick system improved sleep, comfort and ease of use for women. |
| Apr 08 | Regulatory approval EU | Positive | +1.4% | CE Marking for Liverty TIPS Stent Graft to treat portal hypertension across EU. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent news events, including awards, product updates, and an earnings date notice, often saw modest negative or mixed price reactions, even when the underlying news was neutral to positive.
Over recent months, BD has reported awards for supply chain resiliency (Apr 16, 2026), scheduled its Q2 FY26 earnings date (Apr 9, 2026), announced an executive retirement, shared positive clinical data on the PureWick system, and secured EU CE Marking for the Liverty TIPS device (Apr 8, 2026). Price reactions to these updates were mostly modest and sometimes negative despite constructive developments, suggesting a cautious pre-existing sentiment into which today’s conference appearance fits as a routine investor-relations event.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FRANKLIN LAKES, N.J., April 27, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Bank of America Securities Health Care Conference on Tuesday, May 12, 2026 at 11:40 am Eastern Time.
The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com. A replay of the event will be available on the same webpage following its conclusion.
About BD
BD is one of the world's largest pure-play medical technology companies with a Purpose of advancing the world of health™ by driving innovation across medical essentials, connected care, biopharma systems and interventional. The company supports those on the frontlines of healthcare by developing transformative technologies, services and solutions that optimize clinical operations and improve care for patients. Operating across the globe, with more than 60,000 employees, BD delivers billions of products annually that have a positive impact on global healthcare. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase clinical efficiency, improve safety and expand access to healthcare. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X @BDandCo or Instagram @becton_dickinson.
Contacts: | |
Media | Investors |
Matt Marcus | Shawn Bevec SVP, Investor Relations |
View original content:https://www.prnewswire.com/news-releases/bd-to-present-at-bank-of-america-securities-health-care-conference-302754453.html
SOURCE BD (Becton, Dickinson and Company)